论文标题
交替的隔离,以缓解可持续流行
Alternating quarantine for sustainable epidemic mitigation
论文作者
论文摘要
没有药物或疫苗,含有流行病暴发的药物是通过社会疏远而实现的,特别是流动性限制和锁定。这种措施对经济造成了伤害的损失,并且很难长期维持。作为替代方案,我们在这里提出了一种交替的隔离策略,在这种情况下,在每种情况下,一半的人口仍在锁定下,而另一半继续保持活跃,维持活动与隔离之间的常规每周继承。该制度提供了双重分区:\一半的人口仅在一半的时间内相互作用,从而导致传播的急剧减少,与人口全部锁定的锁定相当。一直以来,它以$ 50 \%的$ $ $ $ 5。拟议的每周交替也应对额外的挑战,并与Covid-19具有特定的相关性。确实,SARS-COV-2表现出相对较长的孵化期,其中个人没有症状,但可能已经有助于扩散。我们无法选择性地隔离这些看不见的散布器,我们诉诸于人口范围的限制。但是,在交替的隔离常规下,如果一个人在活跃的一周中暴露在他们的隔离期间,当他们完成隔离时,在大多数情况下,他们将开始表现出症状。因此,该策略在感染阶段分离了大多数症状前个体,导致病毒蔓延迅速下降,从而解决了19009减轻的COVID-19中的主要挑战之一。
Absent a drug or vaccine, containing epidemic outbreaks is achieved by means of social distancing, specifically mobility restrictions and lock-downs. Such measures impose a hurtful toll on the economy, and are difficult to sustain for extended periods. As an alternative, we propose here an alternating quarantine strategy, in which at every instance, half of the population remains under lock-down while the other half continues to be active, maintaining a routine of weekly succession between activity and quarantine. This regime affords a dual partition:\ half of the population interacts for only half of the time, resulting in a dramatic reduction in transmission, comparable to that achieved by a population-wide lock-down. All the while, it enables socioeconomic continuity at $50\%$ capacity. The proposed weekly alternations also address an additional challenge, with specific relevance to COVID-19. Indeed, SARS-CoV-2 exhibits a relatively long incubation period, in which individuals experience no symptoms, but may already contribute to the spread. Unable to selectively isolate these invisible spreaders, we resort to population-wide restrictions. However, under the alternating quarantine routine, if an individual was exposed during their active week, by the time they complete their quarantine they will, in most cases, begin to exhibit symptoms. Hence this strategy isolates the majority of pre-symptomatic individuals during their infectious phase, leading to a rapid decline in the viral spread, thus addressing one of the main challenges in COVID-19 mitigation.